Monday, October 26, 2026 · Daily editionET --:--:--

Maker's videoCMR Surgical · 21 July 2026

For surgeons, access begins with freedom of movement

Watch on YouTube

Against the record

Versius, from CMR Surgical, is at stage 5 of 5 on our ladder: regulator-cleared or mass market. Cleared where approval applies, or widely sold. The latest milestone on its record is from 12 Oct 2026: Stryker agreed to invest about $400 million in CMR Surgical and become the only sales agent for Versius in the US. Stryker also got an option to buy the whole company later. The deal still needs regulatory approval.

This video comes from the maker's own channel, and makers show their robots at their best. The stage above comes from dated public records, not from the video.

From the video's description

For surgeons, access begins with freedom of movement. Versius Plus™ was designed around laparoscopic principles and inspired by human biomechanics, helping surgeons work with familiar techniques while benefiting from robotic precision. Features such as: • 5 mm port compatibility • Open console design that keeps surgeons connected to the patient and care team • Patented V-wrist technology that mimics the movement of the human wrist • Flexible port placement options The result is a robotic platform designed to support natural movement, surgical dexterity, and seamless team communication. 🎥 Learn more about the surgeon experience with Versius Plus™ Transforming Surgery. For Good. cmrsurgical.com Connect with us: Twitter: https://twitter.com/CMRSurgical Instagram: https://www.instagram.com/cmrsurgical/ Facebook: https://www.facebook.com/CMRSurgical/ https://www.linkedin.com/company/c…

Written by CMR Surgical on YouTube.